Concepedia

Ronald Bukowski

RB

10

Publications

1.1K

Citations

10

H-Index

1990

Active since

Affiliations

Cleveland Clinic(Current)

Cleveland Foundation

Rotterdam University of Applied Sciences

Ronald Bukowski is an author at Cleveland Clinic specializing in medicine, oncology, and cancer research.

Top concepts

Publications per year

1990–2005

10

Publications

10

Impact of therapy with epoetin alfa on clinical outcomes in patients with nonmyeloid malignancies during cancer chemotherapy in community oncology practice. Procrit Study Group.

John A. Glaspy, Ronald Bukowski, Douglas Steinberg et al. · Journal of Clinical Oncology · 1997 · 705 citations

The Prognostic Value of the Pathological Response to Combination Chemotherapy before Cystectomy in Patients with Invasive Bladder Cancer

Ted A.W. Splinter, Howard I. Scher, L. Denis et al. · The Journal of Urology · 1992 · 131 citations

Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas

Vladimir Kolenko, Qing Wang, M.C. Riedy et al. · The Journal of Immunology · 1997 · 82 citations

Downregulation of JAK3 Protein Levels in T Lymphocytes by Prostaglandin E2 and Other Cyclic Adenosine Monophosphate-Elevating Agents: Impact on Interleukin-2 Receptor Signaling Pathway

Vladimir Kolenko, Patricia Rayman, Biswajit Roy et al. · Blood · 1999 · 73 citations

The prognostic value of the pT-category after combination chemotherapy for patients with invasive bladder cancer who underwent cystectomy. EORTC-GU group.

T Splinter, H I Scher, L. Denis et al. · PubMed · 1990 · 25 citations

, , +9

Rows per page

1–5 of 10